Table 2.
Baseline characteristics of patients after matching (matched to potential confounders using propensity score method)
| High turnover | Normal turnover | p value | |
|---|---|---|---|
| Number of patients | n = 77 | n = 77 | |
| Age (years) (median, range) | 37 (16–66) | 38 (17–64) | 0.516 |
| Gender (male/female) | 21(27%)/56 (73%) | 21(27%)/56(73%) | 1.0 |
| Duration of disease (months) (median, range) | 24 (1–120) | 24 (1–150) | 0.928 |
| Prior antithyroid drug use | 69(90%) | 67(87%) | 0.616 |
| Duration of antithyroid drug use (months) (median, range) | 18 (0–120) | 24 (0–150) | 0.604 |
| WHO goitre grading | |||
| 0 | 2 (3%) | 3(4%) | 0.857 |
| 1 | 21(27%) | 19 (25%) | |
| 2 | 54 (70%) | 55 (71%) | |
| First-dose RAI 1 activity (mCi) (median, range) | 7 (5–15) | 5 (5–15) | 0.895 |
Two groups matched for potential confounders (age, sex, duration of disease, prior ATD use, goitre grading, RAI activity used)